AusBiotech 2016 Program

AusBiotech 2015: Monday Sessions

Registration Desk Open


 BioIndustry Exhibition Viewing with Tea & Coffee

9:00am - 9:45am

Room 203/204

Welcome to IBS 2016 and AusBiotech 2016

Glenn Cross, CEO, AusBiotech Ltd

Prof Francesco Nicotra, Vice-President of IUPAC Division III, University of Milano-Bicocca, Italy

Senior Victorian Government representative 

 9:45am - 10:30am

Plenary Session 1 l  

Chair: Glenn Cross, CEO, AusBiotech Ltd

Paul Perreault, CEO and Managing Director, CSL Ltd, USA 

100 years old … and just getting started

CSL is Australia’s most successful biotech and this year it will spend more than $USD600 million on R&D. CEO Paul Perreault will discuss his decision to locate CSL’s global R&D hub in Melbourne, his vision for a renaissance in Australian 

biotechnology and his view of the elements needed for business success.



Morning Tea & Networking with BioIndustry Exhibitors


Concurrent Stream 1

Concurrent Stream 2


New technologies and developments in Clinical Trials:

Chair: Dr Meera Verma, Acting Chief Executive, TechInSA

Michael Winlo, CEO, Linear Clinical Research Ltd

National Innovation and Science Agenda Update

Chair: Dr Anna Lavelle, Principal Advisor, AusBiotech Ltd

Bill Ferris AC, Co-Chairman & Co-Founding Partner, CHAMP Private Equity

Sue MacLeman, Chief Executive Officer, MTP Connect - Medical Technologies and Pharmaceuticals Growth Centre

Peter Chesworth, Head of Division, Innovation Programs, Department of Industry, Innovation and Science

Hank Sciberras, Partner, Tax, Deloitte 




Lunch & Networking with BioIndustry Exhibitors 

12:30pm - 1:15pm 

AusBiotech Annual General Meeting

Julie Phillips, Chair, AusBiotech Ltd and the AusBiotech Board invite all members to join the Annual General Meeting.

Lunch provided.


Concurrent Stream 1

Concurrent Stream 2
1:30pm -3:00pm

Collaboration for innovation - drug development in the modern biopharma era

Prof Bill Charman, Dean, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University

Dr Warwick Tong, Chief Executive Officer, Cancer Therapeutics CRC (CTX)


Victorian Government Session


BioSimilars: The science, the operating environment and the opportunity

Chair: Sean Lybrand, Director, Value Access and Policy, Amgen Australia

Dr Sundar Ramanan, Director, Regulatory and R&D Policy, Amgen

Ric Morgan, Special Counsel, Allens

Frederic Lefebvre, Principal, ANZ, IMS Consulting Group


3:00pm - 3:30pm

Afternoon Tea & Networking with BioIndustry Exhibitors

3:30pm - 5:00pm

Room 203/204

J&J Industry Award presentations

Chair: Glenn Cross, CEO, AusBiotech Ltd

Plenary Session 2 l Global update: Key issues facing Big Pharma globally

Chair: Loraine Chiroiu, Deputy CEO, AusBiotech Ltd

Dr Stephen Yoder, Head, Speciality Pharmaceuticals Search & Evaluation, BMS Business Development, Bristol-Myers Squibb 

Dr BG Rhee, President, Green Cross Holdings

Dr Reginald Seeto, Head of Partnering and Strategy, MedImmune 

Dr Kevin J. Lynch, Vice President, Search and Evaluation, Abbvie

5:00pm - 6:30pm

IBS 2016 and AusBiotech 2016 Welcome Reception

Supported by CSL


AusBiotech 2015: Tuesday Sessions

Registration Desk Open 

7:30am - 8:30am

MasterControl Business Breakfast: How to make life changing products available to more people sooner.

Presenter: Chad Fox - President of MasterControl Asia

Join us and experience our version of MasterControl quality management. You will see first hand the essence of our mission statement; To make life changing products available to more people sooner.

Spaces are limited, please express interest during the registration process. Spaces will be confirmed in early September.



BioIndustry Exhibition Open

8:45am - 10:30am

Room 203/204

Chair: Glenn Cross, CEO, AusBiotech Ltd

Plenary Session 3 | Biotechnology and innovation: risk and precaution - social license or not?
Sir Peter Gluckman,
Chief Science Advisor to the Prime Minister, Office of the Prime Minister, New Zealand



Plenary Session 4 l Millis Oration 

Introduction: Dr Andrew Cuthbertson, Chief Scientific Officer and R&D Director, CSL
Prof Ian Gust, Professorial Fellow, University of Melbourne


Plenary Session 5 | 


10:30am - 11:00am

Morning Tea and Networking with BioIndustry Hall Exhibitors


Concurrent Stream 1 

Concurrent Stream 2 

Concurrent Stream 3

11:00 - 12:30pm

Recent Developments in Australian and US Patent Law in the Life Sciences Industry, including Post-Grant Proceedings

Introduction: Jenny Petering, Of Counsel, FB Rice

Chair: Dr Lisa Haile, Partner, DLA Piper

Nicholas Tyacke, Partner, DLA Piper

Geraldine Farrell, General Counsel & Vice President Operations, Nexvet Biopharma plc

Patrick McManamny, Partner, FB Rice


Establishing better links between industry and research institutes

Chair: Dr Julian Chick, Chief Operating Officer, Admedus Limited

Julian Clarke, Head, Business Development, WEHI

James Dromey, Head of Commercialisation & Legal, Murdoch Childrens Research Institute

Dr Keith McLean, Director, Manufacturing Flagship, CSIRO  

Bill McKeon, COO/Chief strategy development officer, Texas Medical Centre innovation

Patheon session




12:30 - 1:30pm

Lunch & Networking with BioIndustry Exhibitors

1:30 - 3:00pm

Global BioPolicy

Chair: Dr Anna Lavelle, Principal Advisor, AusBiotech Ltd

Andrew Casey, President & CEO, BIOTECanada

Dr Viola Bronsema, CEO & Secretary General, BIO Deutschland, Germany

The future of the Australian Regenerative Medicine sector 

Introduction: Silvio Tiziani, Chief Operating Officer, Australian Regenerative Medicine Institue & Executive Director, EMBL Australia

Chair: Megan Munsie, Head-Education, Ethics, Law & Community Awareness Unit

Paul Anderson, Chief Executive Officer, Orthocell

Sue MacLeman, Chief Executive Officer, MTPConnect Ltd

Tim Oldham, Chief Executive Officer, Cell Therapies Pty Ltd

Professor Martin Pera, Chair, Stem Cell Sciences, University of Melbourne

Cyber Risks for Life Science Companies

Travis McIntosh, Assistant VP, Life Science Specialist, Asia Pacific Zone Chubb

Shane Aitken, Chief Operating Officer, Avatar Brokers Pty Ltd

Warren Dunn, Partner, EY Fraud Investigation & Dispute Services


3:00 - 3:30pm

Afternoon Tea & Networking with BioIndustry Exhibitors

3:30 - 5:00pm

Room 203/204

Plenary Session 6 | Early stage Life Sciences Investment - Global Perspective


Chair: Lawrence Gozlan, CEO, Scientia Capital

Jeremy Curnock Cook, Managing Director and Executive Chairman, BioScience Managers

Warren Dunnavant, Director Healthcare Investment Banking, ROTH Capital

Dr Andrew Kelly, Executive Director, BioPacific Partners


7:00 - 11:00pm

AusBiotech Official Conference Dinner  
Peninsula – Atlantic Group, Shed 14 Central Pier

Supported by Patheon


AusBiotech 2015: Wednesday Sessions

Registration Desk & BioIndustry Opens

10:00am - 3:00pm

BioIndustry Exhibition Hall Trade Day

9:30 - 10:30am

Room 203/204
Plenary Session 7
l Successful commercialisation of life science research

Chair: Dr Anna Lavelle, Principal Advisor, AusBiotech Ltd

Hugh Alsop, Chief Executive Office, Hatchtech Pty Ltd
Prof Darren Kelly
, CEO & Managing Director, OccuRx Pty Ltd
Dr Dean Moss, CEO, UniQuest Pty Ltd

10:30am - 11:00am

Morning Tea and Networking with BioIndustry Exhibitors 

11:00am - 11:20am

Room 203/204

Chair: Glenn Cross, CEO, AusBiotech Ltd

Plenary Session 8 l Collaborations between institution, how to grow a world class collaborative medical centre

Robert Robins, President, Texas Medical Centre


11:20am - 11:40am

 Plenary Session 9

Chair: Glenn Cross, CEO, AusBiotech Ltd 



 11:40am - 12:00pm

Plenary Session 10 Update on the UK Life Science Sector

Chair: Glenn Cross, CEO, AusBiotech Ltd

Dr Jon Mowles, Life Sciences Specialist, UKTI 

12:00pm - 12:30pm 

Plenary Session 11 The Science of Swisse

Chair: Glenn Cross, CEO, AusBiotech Ltd

Radek Sali, Chief Executive Officer, Swisse Wellness Pty Ltd


12:30pm - 1.30pm

Lunch and Networking with BioIndustry Exhibitors

1:40pm - 2:00pm

Room 203/204

Look back at the AusBiotech Strategic Plan 2013 - 2016 and look toward the future

Julie Phillips, Chair, Ausbiotech Ltd

2:00pm - 2:20pm

Plenary Session 12 Transformation, Developments, Opportunities and Future of Global CRO Market

Sanjeev Kumar, Industry Manager, Transformational Health: Life sciences, Frost & Sullivan

2:20pm - 3:00pm

Plenary Session 13Nanoparticles for therapy and diagnosis of Alzheimer Disease – A European Union example of translation of academic results

Prof Francesco Nicotra, Vice-President of IUPAC Division III, University of Milano-Bicocca, Italy

3:00pm - 3:45pm

Afternoon Tea and Networking with BioIndustry Exhibitors 

3:45pm - 4:30pm

Plenary Session 15

Dr Viola Bronsema, Secretary General and CEO, BIO Deutschland

4:30pm - 4:45pm

AusBiotech 2016 Closing

Handover to the 2017 conference

4:45pm - 6.00pm

International BioFest Networking Reception, networking for all three BioFest events
Canapes, drinks, live entertainment and networking